Immune modulation by curcumin: The role of interleukin-10

Critical Reviews in Food Science and Nutrition

Volumn 59, Issue 1, 2019, Pages 89-101

  Mollazadeh, Hamid ^a   Cicero, Arrigo F G ^b   Blesso, Christopher N ^c   Pirro, Matteo ^d   Majeed, Muhammed ^e   Sahebkar, Amirhossein ^f  

^a NORTH KHORASAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF CONNECTICUT   (United States)

^d UNIVERSITY OF PERUGIA   (Italy)

^e SABINSA CORPORATION   (United States)

^f MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

chronic diseases; curcumin; human health; inflammation; interleukin 10

Indexed keywords

ALLERGIES; CELL MEMBRANES; CYTOLOGY; NEURODEGENERATIVE DISEASES; PATHOLOGY; PHYSIOLOGY; SIGNALING; T-CELLS;

CHRONIC DISEASE; CURCUMIN; HUMAN HEALTH; INFLAMMATION; INTERLEUKIN-10;

CELL SIGNALING;

CURCUMIN; INTERLEUKIN 10;

DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOMODULATION; METABOLISM;

CURCUMIN; GENE EXPRESSION REGULATION; HUMANS; IMMUNOMODULATION; INTERLEUKIN-10;

EID: 85053908114     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408398.2017.1358139     Document Type: Review

References (179)

1. Abd Allah, E. S. H., and Gomaa, A. M. S., (2015). Effects of curcumin and captopril on the functions of kidney and nerve in streptozotocin-induced diabetic rats: Role of angiotensin converting enzyme 1. Appl. Physiol. Nutr. Metab. 40:1061–67.
2. Abdollahi, E., Momtazi, A. A., Johnston, T. P., and Sahebkar, A., (2017). Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: A nature-made jack-of-all-trades?. J. Cell. Physiol. doi: 10.1002/jcp.25778. [Epub ahead of print]
3. Aggarwal, B. B., and Sung, B., (2009). Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol. Sci. 30:85–94.
4. Akbari, O., DeKruyff, R. H., and Umetsu, D. T., (2001). Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nature Immunol. 2:725.
5. Akiyama, H., Barger, S., Barnum, S., Bradt, B., and Bauer, J., et al. (2000). Inflammation and alzheimer's disease. Neurobiol. Aging 21:383–421.
6. Anderson, A. C., Reddy, J., Nazareno, R., Sobel, R. A., Nicholson, L. B., and Kuchroo, V. K., (2004). IL-10 plays an important role in the homeostatic regulation of the autoreactive repertoire in naive mice. J. Immunol. 173:828–34.
7. Araújo, C. C., and Leon, L. L., (2001). Biological activities of Curcuma longa L. Mem. Inst. Oswaldo Cruz. 96:723–28.
8. Arimoto, T., Choi, D. Y., Lu, X., Liu, M., and Nguyen, X. V., et al. (2007). Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra. Neurobiol. Aging 28:894–906.
9. Asadullah, K., Sterry, W., Stephanek, K., Jasulaitis, D., and Leupold, M., et al. (1998). IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. J. Clin. Invest. 101:783.
10. Balasa, B., Van Gunst, K., Jung, N., Katz, J. D., and Sarvetnick, N., (2000). IL-10 deficiency does not inhibit insulitis and accelerates cyclophosphamide-induced diabetes in the nonobese diabetic mouse. Cell. Immunol. 202:97–102.
11. Bastos, C. C. C., de Ávila, P. H. M., dos Santos Filho, E. X., de Ávila, R. I., and Batista, A. C., et al. (2016). Use of Bidens pilosa L.(Asteraceae) and Curcuma longa L.(Zingiberaceae) to treat intestinal mucositis in mice: Toxico-pharmacological evaluations. Toxicol. Rep. 3:279–87.
12. Batoulis, H., Recks, M. S., Addicks, K., and Kuerten, S., (2011). Experimental autoimmune encephalomyelitis-achievements and prospective advances. Apmis 119:819–30.
13. Beebe, A. M., Cua, D. J., and de Waal Malefyt, R., (2002). The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev. 13:403–12.
14. Bereswill, S., Muñoz, M., Fischer, A., Plickert, R., and Haag, L. M., et al. (2010). Heimesaat, Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation. PLoS One 5:e15099.
15. Bhattacharyya, S., Hossain, D. M. S., Mohanty, S., Sen, G. S., and Chattopadhyay, S., et al. (2010). Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts. Cell. Mol. Immunol. 7:306–15.
16. Boobalan, G., Dileep, R., Rani, M. U., Kumar, C. S., Kumar, M. V., and Reddy, A. G., (2015). Protective Role of Curcumin and Flunixin Against Acetic Acid− Induced Inflammatory Bowel Disease via Modulating Inflammatory Mediators and Cytokine Profile in Rats. J. Environ. Pathol. Toxicol. Oncol. 34(2015).
17. Borish, L. C., and Steinke, J. W., (2003). 2. Cytokines and chemokines. J. All. Clin. Immunol. 111(S2):S460–75.
18. Brenner, S., Prosch, S., Schenke-Layland, K., Riese, U., Gausmann, U., and Platzer, C., (2003). cAMP-induced Interleukin-10 promoter activation depends on CCAAT/enhancer-binding protein expression and monocytic differentiation. J. Biol. Chem. 278:5597–604.
19. Brock, J. L., and Logan, J., (2016). Sex Differences in the Efficacy of Combined IL-10 and IL-10R1 Gene Therapy for Neuropathic Pain in Mice. Undergraduate Honors Theses. 1131.
20. Camacho-Barquero, L., Villegas, I., Sánchez-Calvo, J. M., Talero, E., and Sánchez-Fidalgo, S., et al. (2007). Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis. Int. Immunopharmacol. 7:333–42.
21. Cates, A. M., Holden, V. I., Myers, E. M., Smith, C. K., Kaplan, M. J., and Kahlenberg, J. M., (2015). Interleukin 10 hampers endothelial cell differentiation and enhances the effects of interferon alpha on lupus endothelial cell progenitors. Rheumatology 54:1114–23.
22. Cervantes-Valencia, M. E., Alcalá-Canto, Y., Sumano-Lopez, H., Ducoing-Watty, A. M., and Gutierrez-Olvera, L., (2016). Effects of Curcuma longa dietary inclusion against Eimeria spp. in naturally-infected lambs. Small Rum. Res. 136:27–35.
23. Chang, H. D., Helbig, C., Tykocinski, L., Kreher, S., and Koeck, J., et al. (2007). Expression of IL-10 in Th memory lymphocytes is conditional on IL-12 or IL-4, unless the IL-10 gene is imprinted by GATA-3. Eur. J. Immunol. 37:807–17.
24. Charoenwanthanang, P., Lawanprasert, S., Phivthong-ngam, L., Piyachaturawat, P., Sanvarinda, Y., and Porntadavity, S., (2011). Effects of Curcuma comosa on the expression of atherosclerosis-related cytokine genes in rabbits fed a high–cholesterol diet. J. Ethnopharmacol. 134:608–13.
25. Chinen, T., Kannan, A. K., Levine, A. G., Fan, X., and Klein, U., et al. (2016) An essential role for the IL-2 receptor in Treg cell function. Nature Immunol. 7:1322–33.
26. Chu, K., Zhou, X., and Luo, B. Y., (2012). Cytokine gene polymorphisms and Parkinson's disease: a meta-analysis. Can. J. Neurol. Sci. 39:58–64.
27. Cianciulli, A., Dragone, T., Calvello, R., Porro, C., and Trotta, T., et al. (2015). IL-10 plays a pivotal role in anti-inflammatory effects of resveratrol in activated microglia cells. Int. Immunopharmacol. 24:369–76.
28. Cilfone, N. A., Ford, C. B., Marino, S., Mattila, J. T., and Gideon, H. P., et al. (2015). Linderman, Computational modeling predicts IL-10 control of lesion sterilization by balancing early host immunity-mediated antimicrobial responses with caseation during Mycobacterium tuberculosis infection. J. Immunol. 194:664–77.
29. Colombel, J., Rutgeerts, P., Malchow, H., Jacyna, M., Nielsen, O., and Forbes, A., et al. (2001). Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease. Gut 49:42–46.
30. Commins, S. P., Borish, L., and Steinke, J. W., (2010). Immunologic messenger molecules: cytokines, interferons, and chemokines. J. All. Clin. Immunol. 125(S2):S53–72.
31. Cong, Y., Wang, L., Konrad, A., Schoeb, T., and Elson, C. O., (2009). Curcumin induces the tolerogenic dendritic cell that promotes differentiation of intestine‐protective regulatory T cells. Eur. J. Immunol. 39:3134–46.
32. Cua, D. J., Groux, H., Hinton, D. R., Stohlman, S. A., and Coffman, R. L., (1999). Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 189:1005–10.
33. Cua, D. J., Hutchins, B., LaFace, D. M., Stohlman, S. A., and Coffman, R. L., (2001). Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis. J. Immunol. 166:602–08.
34. da Silva Lima, M., Quintans-Júnior, L. J., de Santana, W. A, Kaneto, C. M., Soares, C. F., and Villarreal, M. B. P., (2013). Anti-inflammatory effects of carvacrol: evidence for a key role of interleukin-10. Eur. J. Pharmacol. 699:112–17.
35. Da Silva, M. D., Bobinski, F., Sato, K. L., Kolker, S. J., Sluka, K. A., and Santos, A. R., (2015). IL-10 cytokine released from M2 macrophages is crucial for analgesic and anti-inflammatory effects of acupuncture in a model of inflammatory muscle pain. Mol. Neurobiol. 51:19–31.
36. Derosa, G., Maffioli, P., Simental-Mendia, L. E., Bo, S., and Sahebkar, A., (2016). Effect of curcumin on circulating interleukin-6 concentrations: A systematic review and meta-analysis of randomized controlled trials. Pharmacol. Res. 111:394–404.
37. Epstein, J., Docena, G., MacDonald, T. T., and Sanderson, I. R., (2010). Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1β and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease. Br. J. Nutr. 103:824–32.
38. Esmaily, H., Sahebkar, A., Iranshahi, M., Ganjali, S., and Mohammadi, A., et al. (2015). An investigation of the effects of curcumin on anxiety and depression in obese individuals: A randomized controlled trial. Chin. J Integr. Med. 21:332–8.
39. Fan, M., Archbold, T., Lackeyram, D., Liu, Q., Mine, Y., and Paliyath, G., (2012). Consumption of guar gum and retrograded high-amylose corn resistant starch increases IL-10 abundance without affecting pro-inflammatory cytokines in the colon of pigs fed a high-fat diet. J. Animal Sci. 90(S4):278–80.
40. Farrell, E., Fahy, N., Ryan, A. E., Flatharta, C. O., and O'Flynn, L., et al. (2016). vIL-10-overexpressing human MSCs modulate naïve and activated T lymphocytes following induction of collagenase-induced osteoarthritis. Stem Cell Res. Ther. 7:74.
41. Fattori, V., Pinho-Ribeiro, F. A., Borghi, S. M., Alves-Filho, J. C., and Cunha, T. M., et al. (2015). Curcumin inhibits superoxide anion-induced pain-like behavior and leukocyte recruitment by increasing Nrf2 expression and reducing NF-kappaB activation. Inflammation Res. 64:993–1003.
42. Fiorentino, D. F., Bond, M. W., and Mosmann, T., (1989). Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:2081–95.
43. Gabryšová, L., Nicolson, K. S., Streeter, H. B., Verhagen, J., and Sabatos-Peyton, C. A., et al. (2009). Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells. J. Exp. Med. 206:1755–67.
44. Ganjali, S., Blesso, C. N., Banach, M., Pirro, M., Majeed, M., and Sahebkar, A., (2017). Effects of curcumin on HDL functionality. Pharmacol. Res. 119:208–18.
45. Ganjali, S., Sahebkar, A., Mahdipour, E., Jamialahmadi, K., and Torabi, S., et al. (2014). Investigation of the effects of curcumin on serum cytokines in obese individuals: a randomized controlled trial. Sci. World J. 2014:898361.
46. Gazal, M., Valente, M. R., Acosta, B. A., Kaufmann, F. N., and Braganhol, E., et al. (2014). Neuroprotective and antioxidant effects of curcumin in a ketamine-induced model of mania in rats. Eur. J. Pharmacol. 724:132–9.
47. Ghandadi, M., and Sahebkar, A., (2017). Curcumin: An effective inhibitor of interleukin-6. Curr. Pharm. Des. 23, 921–31. [Epub ahead of print]
48. Gopu, B., Dileep, R., Rani, M. U., Kumar, C. S., Kumar, M. V., and Reddy, A. G., (2015). Protective Role of Curcumin and Flunixin Against Acetic Acid-Induced Inflammatory Bowel Disease via Modulating Inflammatory Mediators and Cytokine Profile in Rats. J. Environ. Pathol. Toxicol. Oncol. 34:309–20.
49. Greenhill, C. J., Jones, G. W., Nowell, M. A., Newton, Z., and Harvey, A. K., et al. (2014). Interleukin-10 regulates the inflammasome-driven augmentation of inflammatory arthritis and joint destruction. Arthritis Res. Ther. 16:419.
50. Grünig, G., Corry, D. B., Leach, M. W., Seymour, B. W., Kurup, V. P., and Rennick, D. M., (1997). Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J. Exp. Med. 185:1089–1100.
51. Han, X., and Boisvert, W. A., (2015). Interleukin-10 protects against atherosclerosis by modulating multiple atherogenic macrophage function. Thromb. Haemost. 113:505–12.
52. Heine, G., Drozdenko, G., Grün, J. R., Chang, H. D., Radbruch, A., and Worm, M., (2014). Autocrine IL‐10 promotes human B‐cell differentiation into IgM‐or IgG‐secreting plasmablasts. Eur. J. Immunol. 44:1615–21.
53. Hoppe, J. B., Frozza, R. L., Pires, E. N. S., Meneghetti, A. B., and Salbego, C., (2013). The curry spice curcumin attenuates beta-amyloid-induced toxicity through beta–catenin and PI3K signaling in rat organotypic hippocampal slice culture. Neurol. Res. 35:857–66.
54. Hovsepian, E., Penas, F., Siffo, S., Mirkin, G. A., and Goren, N. B., (2013). IL–10 inhibits the NF–κB and ERK/MAPK–mediated production of pro–inflammatory mediators by up–regulation of SOCS–3 in Trypanosoma cruzi–infected cardiomyocytes. PLoS One 8:e79445.
55. Huang, S., Ullrich, S. E., and Bar–Eli, M., (1999). Regulation of tumor growth and metastasis by interleukin-10: the melanoma experience. J. Interferon Cytokine Res. 19:697–703.
56. Hwang, W. S., Kim, H. I., Kim, Y. J., Kang, B. C., and Lee, H. S., et al. (2013). Pregnancy in postpartum estrus induces inflammatory milk production and catagen specific pup skin inflammation in interleukin-10 deficient mice. J. Dermatol. Sci. 72:225–32.
57. Iranshahi, M., Sahebkar, A., Hosseini, S. T., Takasaki, M., Konoshima, T., and Tokuda, H., (2010). Cancer chemopreventive activity of diversin from Ferula diversivittata in vitro and in vivo. Phytomedicine 17:269–73.
58. Ishizuka, K., Sugimura, K., Homma, T., Matsuzawa, J., and Mochizuki, T., et al. (2001). Influence of interleukin-10 on the interleukin–1 receptor antagonist/interleukin–1β ratio in the colonic mucosa of ulcerative colitis. Digestion 63(S1):22–27.
59. Jia, S., Wei, H., Yu, J., Wei, X., Zhang, X., and Li, J., (2010). Protective effects of curcumin on neonatal rats with necrotizing enterocolitis. Chin. J. Contemp. Ped. 12:132–6.
60. Jian, Y. T., Wang, J. D., Mai, G. F., Zhang, Y. L., and Lai, Z. S., (2004). Modulation of intestinal mucosal inflammatory factors by curcumin in rats with colitis. Ac. J. First Med. Coll. of PLA 24:1353–58.
61. Kanakasabai, S., Casalini, E., Walline, C. C., Mo, C., Chearwae, W., and Bright, J. J., (2012). Differential regulation of CD4+ T helper cell responses by curcumin in experimental autoimmune encephalomyelitis. J. Nutr. Biochem. 23:1498–1507.
62. Kanazawa, M., Kawamura, K., Takahashi, T., Miura, M., and Tanaka, Y., et al. (2015). Multiple therapeutic effects of progranulin on experimental acute ischaemic stroke. Brain 138:1932–48.
63. Kant, V., Gopal, A., Pathak, N. N., Kumar, P., Tandan, S. K., and Kumar, D., (2014). Antioxidant and anti–inflammatory potential of curcumin accelerated the cutaneous wound healing in streptozotocin–induced diabetic rats. Int. Immunopharmacol. 20:322–30.
64. Karimian, M. S., Pirro, M., Johnston, T. P., Majeed, M., and Sahebkar, A., (2017). Curcumin and Endothelial Function: Evidence and Mechanisms of Protective Effects. Curr. Pharm. Des. 33:55–63. doi: 10.2174/1381612823666170222122822. [Epub ahead of print]
65. Karimian, M. S., Pirro, M., Majeed, M., and Sahebkar, A., (2017). Curcumin as a natural regulator of monocyte chemoattractant protein–1. Cytokine Growth Factor Rev. 33:55–63.
66. Karuppagounder, V., Arumugam, S., Thandavarayan, R. A., Sreedhar, R., and Giridharan, V. V., et al. (2016). Curcumin alleviates renal dysfunction and suppresses inflammation by shifting from M1 to M2 macrophage polarization in daunorubicin induced nephrotoxicity in rats. Cytokine 84:1–9.
67. Katsikis, P. D., Chu, C. Q., Brennan, F. M., Maini, R. N., and Feldmann, M., (1994). Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J. Exp. Med. 179:1517–27.
68. Khan, J., Ramadan, K., Korczeniewska, O., Anwer, M. M., Benoliel, R., and Eliav, E., (2015). Interleukin-10 levels in rat models of nerve damage and neuropathic pain. Neurosci. Letters 592:99–106.
69. Kim, O. K., Yoo, S. A., Nam, D. E., Kim, Y., and Kim, E., et al. (2014). Immunomodulatory effects of Curcuma longa L. extract in LP–BM5 murine leukemia viruses–induced murine acquired immune deficiency syndrome. J. Korean Soc. Food Sci. Nutr. 43:1317–24.
70. Kiyota, T., Ingraham, K. L., Swan, R. J., Jacobsen, M. T., Andrews, S. J., and Ikezu, T., (2012). AAV serotype 2/1–mediated gene delivery of anti–inflammatory interleukin-10 enhances neurogenesis and cognitive function in APP+ PS1 mice. Gene Ther. 19:724–33.
71. Kobayashi, T., Hashimoto, S., and Horie, T., (1997). Curcumin inhibition of Dermatophagoides farinea–induced interleukin–5 (IL–5) and granulocyte macrophage–colony stimulating factor (GM–CSF) production by lymphocytes from bronchial asthmatics. Biochem. Pharmacol. 54:819–24.
72. Krishnaswamy, K., and Raghuramulu, N., (1998). Bioactive phytochemicals with emphasis on dietary practices. Indian J. Med. Res. 108:167.
73. Kunnumakkara, A. B., Bordoloi, D., Padmavathi, G., Monisha, J., and Roy, N. K., et al. (2017). Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. Br. J. Pharmacol. 174:1325–48.
74. Kwilasz, A., Grace, P., Serbedzija, P., Maier, S., and Watkins, L., (2015). The therapeutic potential of interleukin-10 in neuroimmune diseases. Neuropharmacology 96:55–69.
75. Lampropoulou, I. T., Stangou, M., Papagianni, A., Didangelos, T., Iliadis, F., and Efstratiadis, G., (2014). TNF–α and microalbuminuria in patients with type 2 diabetes mellitus. J. Diab. Res. 2014:394206.
76. Larmonier, C. B., Uno, J. K., Lee, K. M., Karrasch, T., and Laubitz, D., et al. (2008). Limited effects of dietary curcumin on Th–1 driven colitis in IL–10 deficient mice suggest an IL–10–dependent mechanism of protection. Am. J. Physiol. 295:G1079–G1091.
77. Lauwerys, B. R., Garot, N., Renauld, J. C., and Houssiau, F. A., (2000). Interleukin‐10 blockade corrects impaired in vitro cellular immune responses of systemic lupus erythematosus patients. Arthritis Rheum. 43:1976–81.
78. Lelli, D., Sahebkar, A., Johnston, T. P., and Pedone, C., (2017). Curcumin use in pulmonary diseases: State of the art and future perspectives. Pharmacol. Res. 115:133–48.
79. Leon, L. R., Kozak, W., Rudolph, K., and Kluger, M. J., (1999). An antipyretic role for interleukin-10 in LPS fever in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 276:R81–R89.
80. Li, C., Zhang, L., Chen, Y., Lin, X., and Li, T., (2016). Protective role of adenovirus vector–mediated interleukin-10 gene therapy on endogenous islet β–cells in recent–onset type 1 diabetes in NOD mice. Exp. Ther. Med. 11:1625–32.
81. Lio, D., Licastro, F., Scola, L., Chiappelli, M., and Grimaldi, L., et al. (2003). Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease. Genes Immunity 4:234–38.
82. Llorente, L., Richaud-Patin, Y., García-Padilla, C., Claret, E., and Jakez-Ocampo, J., et al. (2000). Clinical and biologic effects of anti–interleukin‐10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum. 43:1790–1800.
83. Locati, M., Mantovani, A., and Sica, A., (2012). Macrophage activation and polarization as an adaptive component of innate immunity. Adv. Immunol. 120:163–84.
84. Ma, C., Ma, Z., Fu, Q., and Ma, S., (2013). Curcumin attenuates allergic airway inflammation by regulation of CD4+ CD25+ regulatory T cells (Tregs)/Th17 balance in ovalbumin–sensitized mice. Fitoterapia 87:57–64.
85. Maheshwari, R. K., Singh, A. K., Gaddipati, J., and Srimal, R. C., (2006). Multiple biological activities of curcumin: a short review. Life Sci. 78:2081–87.
86. Mannarino, E., and Pirro, M., (2008). Endothelial injury and repair: a novel theory for atherosclerosis. Angiology 59(S2):69S–72S.
87. Maynard, C. L., Elson, C. O., Hatton, R. D., and Weaver, C. T., (2012). Reciprocal interactions of the intestinal microbiota and immune system. Nature 489:231–41.
88. McCann, M. J., Johnston, S., Reilly, K., Men, X., and Burgess, E. J., et al. (2014). The effect of turmeric (Curcuma longa) extract on the functionality of the solute carrier protein 22 A4 (SLC22A4) and interleukin-10 (IL–10) variants associated with inflammatory bowel disease. Nutrients 6:4178–90.
89. McKinstry, K. K., Strutt, T. M., Buck, A., Curtis, J. D., and Dibble, J. P., et al. (2009). IL–10 deficiency unleashes an influenza–specific Th17 response and enhances survival against high–dose challenge. J. Immunol. 182:7353–63.
90. Milligan, E. D., Langer, S. J., Sloane, E. M., He, L., and Wieseler-Frank, J., et al. (2005). Controlling pathological pain by adenovirally driven spinal production of the anti‐inflammatory cytokine, interleukin‐10. Eur. J. Neurosci. 21:2136–48.
91. Milligan, E. D., Sloane, E. M., Langer, S. J., Hughes, T. S., and Jekich, B. M., et al. (2006). Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain. Pain 126:294–308.
92. Mingomataj, E. Ç., and Bakiri, A. H., (2016). Regulator versus effector paradigm: interleukin-10 as indicator of the switching response. Clin. Rev. All. Immunol. 50:97–113.
93. Mirzaei, H., Naseri, G., Rezaee, R., Mohammadi, M., and Banikazemi, Z., et al. (2016). Curcumin: A new candidate for melanoma therapy?. Int. J. Cancer 139:1683–95.
94. Mohammadi, A., Sahebkar, A., Iranshahi, M., Amini, M., and Khojasteh, R., et al. (2013). Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial. Phytother. Res. 27:374–9.
95. Molina-Jijón, E., Aparicio-Trejo, O. E., Rodríguez-Muñoz, R., León-Contreras, J. C., and del Carmen Cárdenas-Aguayo, M., et al. (2016). The nephroprotection exerted by curcumin in maleate‐induced renal damage is associated with decreased mitochondrial fission and autophagy. BioFactors 42:686–702.
96. Momtazi, A. A., Derosa, G., Maffioli, P., Banach, M., and Sahebkar, A., (2016b). Role of microRNAs in the Therapeutic Effects of Curcumin in Non–Cancer Diseases. Mol. Diagn. Ther. 20:335–45.
97. Momtazi, A. A., and Sahebkar, A., (2016). Difluorinated Curcumin: A Promising Curcumin Analogue with Improved Anti–Tumor Activity and Pharmacokinetic Profile. Curr. Pharmac. Des. 22:4386–97.
98. Momtazi, A. A., Shahabipour, F., Khatibi, S., Johnston, T. P., Pirro, M., and Sahebkar, A., (2016a). Curcumin as a MicroRNA Regulator in Cancer: A Review. Rev. Physiol. Biochem. Pharmacol. 171:1–38.
99. Moore, K. W., de Waal Malefyt, R., Coffman, R. L., and O'Garra, A., (2001). Interleukin-10 and the interleukin-10 receptor. Ann. Rev. Immunol. 19:683–765.
100. Myles, I. A., Pincus, N. B., Fontecilla, N. M., and Datta, S. K., (2014). Effects of parental omega–3 fatty acid intake on offspring microbiome and immunity. PLoS One 9:e87181.
101. Naito, Y., Takagi, T., and Higashimura, Y., (2014). Heme oxygenase–1 and anti–inflammatory M2 macrophages. Arch. Biochem. Biophysics 564:83–88.
102. Nanji, A. A., Jokelainen, K., Tipoe, G. L., Rahemtulla, A., Thomas, P., and Dannenberg, A. J., (2003). Curcumin prevents alcohol–induced liver disease in rats by inhibiting the expression of NF–κB–dependent genes. Am. J. Physiol. Gastroint. Liver Physiol. 284:G321–G327.
103. Ng, T., Britton, G. J., Hill, E. V., Verhagen, J., Burton, B. R., and Wraith, D. C., (2013). Regulation of adaptive immunity; the role of interleukin-10. Frontiers Immunol. 4:129.
104. Panahi, Y., Alishiri, G. H., Parvin, S., and Sahebkar, A., (2016b). Mitigation of Systemic Oxidative Stress by Curcuminoids in Osteoarthritis: Results of a Randomized Controlled Trial. J. Diet. Suppl. 13:209–20.
105. Panahi, Y., Badeli, R., Karami, G. R., and Sahebkar, A., (2015a). Investigation of the efficacy of adjunctive therapy with bioavailability–boosted curcuminoids in major depressive disorder. Phytother. Res. 29:17–21.
106. Panahi, Y., Hosseini, M. S., Khalili, N., Naimi, E., Majeed, M., and Sahebkar, A., (2015b). Antioxidant and anti–inflammatory effects of curcuminoid–piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta–analysis. Clin. Nutr. 34:1101–8.
107. Panahi, Y., Hosseini, M. S., Khalili, N., Naimi, E., and Simental–Mendia, L. E., et al. (2016a). Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: A post–hoc analysis of a randomized controlled trial. Biomed. Pharmacother. 82:578–82.
108. Panahi, Y., Khalili, N., Hosseini, M. S., Abbasinazari, M., and Sahebkar, A., (2014). Lipid–modifying effects of adjunctive therapy with curcuminoids–piperine combination in patients with metabolic syndrome: results of a randomized controlled trial. Compl. Ther Med. 22:851–7.
109. Panahi, Y., Khalili, N., Sahebi, E., Namazi, S., and Karimian, M. S., et al. (2017b). Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial. Inflammopharmacol. 25:25–31.
110. Panahi, Y., Kianpour, P., Mohtashami, R., Jafari, R., Simental–Mendia, L. E., and Sahebkar, A., (2016c). Curcumin Lowers Serum Lipids and Uric Acid in Subjects With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial. J. Cardiovasc. Pharmacol. 68:223–9.
111. Panahi, Y., Kianpour, P., Mohtashami, R., Jafari, R., Simental–Mendia, L. E., and Sahebkar, A., (2017a). Efficacy and Safety of Phytosomal Curcumin in Non–Alcoholic Fatty Liver Disease: A Randomized Controlled Trial. Drug Res. 67:244–51.
112. Panahi, Y., Sahebkar, A., Amiri, M., Davoudi, S. M., and Beiraghdar, F., et al. (2012a). Improvement of sulphur mustard–induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double–blind, placebo–controlled trial. Br. J. Nutr. 108:1272–9.
113. Panahi, Y., Sahebkar, A., Parvin, S., and Saadat, A., (2012b). A randomized controlled trial on the anti–inflammatory effects of curcumin in patients with chronic sulphur mustard–induced cutaneous complications. Ann. Clin. Biochem. 49(Pt6):580–8.
114. Pari, L., Tewas, D., and Eckel, J., (2008). Role of curcumin in health and disease. Arch. Physiol. Biochem. 114:127–49.
115. Pavkov, M. E., Nelson, R. G., Knowler, W. C., Cheng, Y., Krolewski, A. S., and Niewczas, M. A., (2015). Elevation of circulating TNF receptors 1 and 2 increases the risk of end–stage renal disease in American Indians with type 2 diabetes. Kidney Int. 87:812–9.
116. Peelen, E., Thewissen, M., Knippenberg, S., Smolders, J., and Muris, A. H., et al. (2013). Fraction of IL–10+ and IL–17+ CD8 T cells is increased in MS patients in remission and during a relapse, but is not influenced by immune modulators. J. Neuroimmunol. 258:77–84.
117. Pirro, M., Bagaglia, F., Paoletti, L., Razzi, R., and Mannarino, M. R., (2008). Hypercholesterolemia–associated endothelial progenitor cell dysfunction. Ther. Adv. Cardiov. Dis. 2:329–39.
118. Pirro, M., Cagini, L., Mannarino, M. R., Andolfi, M., and Potenza, R., et al. (2016). Reduced survival in patients with early–stage non–small–cell lung cancer is associated with high pleural endothelial progenitor cell levels. Eur. J Cardiothor. Surg. 50:1053–59.
119. Pirro, M., Cagini, L., Paciullo, F., Pecoriello, R., and Mannarino, M. R., et al. (2013). Baseline and post–surgery endothelial progenitor cell levels in patients with early–stage non–small–cell lung carcinoma: impact on cancer recurrence and survival. Eur. J. Cardiothor. Surg. 44:e245–52.
120. Pirro, M., Schillaci, G., Romagno, P. F., Mannarino, M. R., and Bagaglia, F., et al. (2009). Influence of short–term rosuvastatin therapy on endothelial progenitor cells and endothelial function. J. Cardiovasc. Pharmacol. Ther. 14:14–21.
121. Pirro, M., Schillaci, G., Savarese, G., Gemelli, F., and Mannarino, M. R., et al. (2004). Attenuation of inflammation with short–term dietary intervention is associated with a reduction of arterial stiffness in subjects with hypercholesterolaemia. Eur. J. Cardiovasc. Prev. Rehab. 11:497–502.
122. Poole, S., Cunha, F., Selkirk, S., Lorenzetti, B., and Ferreira, S., (1995). Cytokine‐mediated inflammatory hyperalgesia limited by interleukin‐10. Br. J. Pharmacol. 115:684–8.
123. Pulido–Moran, M., Moreno–Fernandez, J., Ramirez–Tortosa, C., and Ramirez–Tortosa, M., (2016). Curcumin and Health. Molecules 21:264.
124. Rahmani, S., Asgary, S., Askari, G., Keshvari, M., and Hatamipour, M., et al. (2016). Treatment of Non–alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo–controlled Trial. Phytother. Res. 30:1540–8.
125. Ramezani, M., Hatamipour, M., and Sahebkar, A., (2017). Promising Anti–tumor properties of Bisdemethoxycurcumin: A Naturally Occurring Curcumin Analogue. J. Cell. Physiol. doi: 10.1002/jcp.25795. [Epub ahead of print]
126. Rezaee, R., Momtazi, A. A., Monemi, A., and Sahebkar, A., (2017). Curcumin: A potentially powerful tool to reverse cisplatin–induced toxicity. Pharmacol. Res. 117:218–27.
127. Roberti, M., Ricottini, L., Capponi, A., Sclauzero, E., and Vicenti, P., et al. (2014). Immunomodulating treatment with low dose interleukin–4, interleukin-10 and interleukin–11 in psoriasis vulgaris. J. Biol. Regul. Homeost. Agents 28:133–9.
128. Sabat, R., Grütz, G., Warszawska, K., Kirsch, S., Witte, E., Wolk, K., and Geginat, J., (2010). Biology of interleukin-10. Cytokine Growth Factor Rev. 21:331–44.
129. Sahbaie, P., Sun, Y., Liang, D. Y., Shi, X. Y., and Clark, J. D., (2014). Curcumin treatment attenuates pain and enhances functional recovery after incision. Anesthesia Analgesia 118:1336–44.
130. and Sahebkar, A., (2010). Molecular mechanisms for curcumin benefits against ischemic injury. Fertil. Steril. 94:e75–6
131. and Sahebkar, A., (2013). Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome?. BioFactors 39:197–208.
132. and Sahebkar, A., (2014b). Are curcuminoids effective C–reactive protein–lowering agents in clinical practice? Evidence from a meta–analysis. Phytother. Res. 28:633–42.
133. and Sahebkar, A., (2014a). Curcuminoids for the management of hypertriglyceridaemia. Nat Rev. Cardiol. 11:123.
134. and Sahebkar, A., (2015). Dual effect of curcumin in preventing atherosclerosis: the potential role of pro–oxidant–antioxidant mechanisms. Nat. Prod. Res. 29:491–2.
135. Sahebkar, A., Mohammadi, A., Atabati, A., Rahiman, S., and Tavallaie, S., et al. (2013). Curcuminoids modulate pro–oxidant–antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals. Phytother. Res. 27:1883–8.
136. Sánchez-Calvo, J. M., Villegas, I., Sánchez-Fidalgo, S., Camacho-Barquero, L., and Talero, E., et al. (2009). Protective effect of curcumin, a Curcuma longa constituent, in early colonic inflammation in rats. Drug Devel. Res. 70:425–37.
137. Schwenkgrub, J., Joniec–Maciejak, I., Sznejder–Pachołek, A., Wawer, A., and Ciesielska, A., et al. (2013). Effect of human interleukin-10 on the expression of nitric oxide synthases in the MPTP–based model of Parkinson's disease. Pharmacol. Rep. 65:44–49.
138. Shattuck–Brandt, R. L., Varilek, G. W., Radhika, A., Yang, F., Washington, M. K., and DuBois, R. N., (2000). Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL–10−/− mice. Gastroenterology 118:337–345.
139. Shiri, S., Alizadeh, A. M., Baradaran, B., Farhanghi, B., and Shanehbandi, D., et al. (2014). Dendrosomal curcumin suppresses metastatic breast cancer in mice by changing m1/m2 macrophage balance in the tumor microenvironment. Asian Pac. J. Cancer Prev. 16:3917–22.
140. Shouval, D. S., Ouahed, J., Biswas, A., Goettel, J. A., and Horwitz, B. H., et al. (2014). Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans. Adv. Immunol. 122:177.
141. Singh, S., and Khar, A., (2006). Biological effects of curcumin and its role in cancer chemoprevention and therapy. Anticancer Agents Med. Chem. 6:259–70.
142. Singh, V., Rana, M., Jain, M., Singh, N., and Naqvi, A., et al. (2015). Curcuma oil attenuates accelerated atherosclerosis and macrophage foam–cell formation by modulating genes involved in plaque stability, lipid homeostasis and inflammation. Br. J. Nutr. 113:100–13.
143. Sloane, E., Ledeboer, A., Seibert, W., Coats, B., and Van Strien, M., et al. (2009). Anti–inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG–EAE behavioral and anatomical symptom treatment with cytokine gene therapy. Brain Behav. Immun. 23:92–100.
144. Song, W. B., Wang, Y. Y., Meng, F. S., Zhang, Q. H., and Zeng, J. Y., et al. (2010). Curcumin protects intestinal mucosal barrier function of rat enteritis via activation of MKP–1 and attenuation of p38 and NF–κB activation. PLoS One 5:e12969.
145. Spera, P. A., Ellison, J. A., Feuerstein, G. Z., and Barone, F. C., (1998). IL–10 reduces rat brain injury following focal stroke. Neurosci. Letters 251:189–92.
146. Sreedhar, R., Arumugam, S., Thandavarayan, R. A., Karuppagounder, V., and Watanabe, K., (2016). Curcumin as a therapeutic agent in the chemoprevention of inflammatory bowel disease. Drug Discov. Today 21:843–49.
147. Steidler, L., Hans, W., Schotte, L., Neirynck, S., and Obermeier, F., et al. (2000). Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289:1352–55.
148. Steinke, J. W., and Borish, L., (2006). 3. Cytokines and chemokines. J. All. Clin. Immunol. 117(S2):S441–5.
149. Stewart, C. A., Metheny, H., Iida, N., Smith, L., and Hanson, M., et al. (2013). Interferon–dependent IL–10 production by Tregs limits tumor Th17 inflammation. J. Clin. Invest. 123:4859–74.
150. St–Pierre, A. C., Bergeron, J., Pirro, M., Cantin, B., and Dagenais, G. R., et al. (2003). Quebec Cardiovascular, Effect of plasma C–reactive protein levels in modulating the risk of coronary heart disease associated with small, dense, low–density lipoproteins in men. The Quebec Cardiovascular Study). Am. J. Cardiol. 91:555–8.
151. Sunagawa, Y., Morimoto, T., Wada, H., Takaya, T., and Katanasaka, Y., et al. (2011). A natural p300–specific histone acetyltransferase inhibitor, curcumin, in addition to angiotensin–converting enzyme inhibitor, exerts beneficial effects on left ventricular systolic function after myocardial infarction in rats. Circ. J. 75:2151–59.
152. Teymouri, M., Pirro, M., Johnston, T. P., and Sahebkar, A., (2016). Curcumin as a multifaceted compound against human papilloma virus infection and cervical cancers: A review of chemistry, cellular, molecular, and preclinical features. BioFactors 43:331–46. doi: 10.1002/biof.1344. [Epub ahead of print]
153. Tham, C. L., Liew, C. Y., Lam, K. W., Mohamad, A. S., and Kim, M. K., et al. (2010). A synthetic curcuminoid derivative inhibits nitric oxide and proinflammatory cytokine synthesis. Eur. J. Pharmacol. 628:247–54.
154. Thaxton, J. E., and Sharma, S., (2010). Interleukin‐10: A Multi‐Faceted Agent of Pregnancy. Am. J. Repr. Immunol. 63:482–91.
155. Topcu–Tarladacalisir, Y., Sapmaz–Metin, M., and Karaca, T., (2016). Curcumin counteracts cisplatin–induced nephrotoxicity by preventing renal tubular cell apoptosis. Ren. Fail. 1–8.
156. Trenova, A. G., Manova, M. G., Kostadinova, I. I., Murdjeva, M. A., and Hristova, D. R., et al. (2011). Clinical and laboratory study of pro–inflammatory and antiinflammatory cytokines in women with multiple sclerosis. Folia Medica 53:29–35.
157. Tu, C. T., Han, B., Yao, Q. Y., and Zhang, Y. A., et al. (2012). Curcumin attenuates Concanavalin A–induced liver injury in mice by inhibition of Toll–like receptor (TLR) 2, TLR4 and TLR9 expression. Int. immunopharmacol. 12:151–7.
158. Tukhovskaya, E. A., Turovsky, E. A., Turovskaya, M. V., Levin, S. G., and Murashev, A. N., et al. (2014). Anti–inflammatory cytokine interleukin-10 increases resistance to brain ischemia through modulation of ischemia–induced intracellular Ca 2+ response. Neurosci. Letters 571:55–60.
159. Ung, V. Y., Foshaug, R. R., MacFarlane, S. M., Churchill, T. A., and Doyle, J. S., et al. (2010). Oral administration of curcumin emulsified in carboxymethyl cellulose has a potent anti–inflammatory effect in the IL–10 gene–deficient mouse model of IBD, Dig. Dis. Sci. 55:1272–77.
160. Vathsala, P. G., Dende, C., Nagaraj, V. A., Bhattacharya, D., and Das, G., et al. (2012). Curcumin–arteether combination therapy of Plasmodium berghei–infected mice prevents recrudescence through immunomodulation. PLoS One 7:e29442.
161. Vyas, D., Gupt, S., Dixit, V., Anita, K., and Kaur, S., (2015). To study the effect of curcumin on the growth properties of circulating endothelial progenitor cells, In vitro cellular & developmental biology. Animal 51:488–94.
162. Wang, J., Wang, H., Zhu, R., Liu, Q., Fei, J., and Wang, S., (2015). Anti–inflammatory activity of curcumin–loaded solid lipid nanoparticles in IL–1β transgenic mice subjected to the lipopolysaccharide–induced sepsis. Biomaterials 53:475–83.
163. Wang, S., Li, H., Zhang, M., Yue, L. T., and Wang, C. C., et al. (2016). Curcumin ameliorates experimental autoimmune myasthenia gravis by diverse immune cells. Neurosci. Lett. 626:25–34.
164. Wang, Y., Chen, Q., Zhang, Z., Jiang, F., Meng, X., and Yan, H., (2015). Interleukin-10 overexpression improves the function of endothelial progenitor cells stimulated with TNF–alpha through the activation of the STAT3 signaling pathway. Int. J. Mol. Med. 35:471–7.
165. Wilkerson, J. L., Gentry, K. R., Dengler, E. C., Wallace, J. A., and Kerwin, A. A., et al. (2012). Intrathecal cannabilactone CB 2 R agonist, AM1710, controls pathological pain and restores basal cytokine levels. Pain 153:1091–106.
166. Williams, L., Bradley, L., Smith, A., and Foxwell, B., (2004). Signal transducer and activator of transcription 3 is the dominant mediator of the anti–inflammatory effects of IL–10 in human macrophages. J. Immunol. 172:567–76.
167. Wolkmer, P., da Silva, C. B, Paim, F. C., Duarte, M. M., and Castro, V., et al. (2013). Pre–treatment with curcumin modulates acetylcholinesterase activity and proinflammatory cytokines in rats infected with Trypanosoma evansi. Parasitol. Int. 62:144–9.
168. Wu, S., and Xiao, D., (2016). Effect of curcumin on nasal symptoms and airflow in patients with perennial allergic rhinitis. Ann. All. Asthma Immunol. 117:697–702. e1.
169. Wu, S. J., Tam, K. W., Tsai, Y. H., Chang, C. C., and Chao, J. C. J., (2010). Curcumin and saikosaponin a inhibit chemical–induced liver inflammation and fibrosis in rats. Am. J. Chin. Med. 38:99–111.
170. Xiao, Z., Mohamood, A. S., Uddin, S., Gutfreund, R., and Nakata, C., et al. (2011). Inhibition of Fas ligand in NOD mice unmasks a protective role for IL–10 against insulitis development. Am. J. Pathol. 179:725–32.
171. Xu, K., Liu, L., Dere, R., Mai, E., and Erickson, R., et al. (2013). Characterization of the drug–to–antibody ratio distribution for antibody–drug conjugates in plasma/serum. Bioanalysis 5:1057–71.
172. Yang, A. S., and Lattime, E. C., (2003). Tumor–induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T–cell responses. Cancer Res. 63:2150–57.
173. Yeh, C. H., Chen, T. P., Wu, Y. C., Lin, Y. M., and Lin, P. J., (2005). Inhibition of NFκB Activation with Curcumin Attenuates Plasma Inflammatory Cytokines Surge and Cardiomyocytic Apoptosis Following Cardiac Ischemia/Reperfusion. J. Surg. Res. 125:109–16.
174. Yu, S., Wang, X., He, X., Wang, Y., and Gao, S., et al. (2016). Curcumin exerts anti–inflammatory and antioxidative properties in 1–methyl–4–phenylpyridinium ion (MPP+)–stimulated mesencephalic astrocytes by interference with TLR4 and downstream signaling pathway. Cell Stress Chap. 21:697–705.
175. Zhang, M., Zheng, J. J., and Xia, J., (2006). Curcumin regulated shift from Th1 to Th2 in trinitrobenzene sulphonic acid‐induced chronic colitis. Acta Pharmacol. Sin. 27:1071–77.
176. Zhao, Q., Xie, X., Fan, Y., Zhang, J., and Jiang, W., et al. (2015). Phenotypic dysregulation of microglial activation in young offspring rats with maternal sleep deprivation–induced cognitive impairment. Sci. Rep. 5:9513.
177. Zhu, R., Zhou, M., He, J., Ding, F., Yu, S., and Xu, G., (2008). Protective effect of curcumin on oleic–induced acute lung injury in rats. Chin. J. Chin. Mat. Med. 33:2141–45.
178. Zhu, X., Li, Q., Chang, R., Yang, D., and Song, Z., et al. (2014). Curcumin alleviates neuropathic pain by inhibiting p300/CBP histone acetyltransferase activity–regulated expression of BDNF and cox–2 in a rat model. PLoS One 9:e91303.
179. Zuccotti, G., Trabattoni, D., Morelli, M., Borgonovo, S., Schneider, L., and Clerici, M., (2008). Immune modulation by lactoferrin and curcumin in children with recurrent respiratory infections. J. Biol. Regul. Homeost. Agents 23:119–23.